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Implementation and Maintenance of Practice Guidelines
to Decrease Central Line Associated Bloodstream
Infections by Minimizing Line Manipulation
Kelsey Johnson, Azure Grossman. Blood and Marrow
Transplant, Froedtert Hospital, Milwaukee, WI
Background: The adult blood and marrow transplant pop-
ulation is at high risk for central line associated bloodstream
infections (CLABSI). CLABSI remains a large cause of
morbidity, increased cost, prolonged hospitalization and
mortality in this population. One source of these infections is
line manipulation; speciﬁcally at the central venous access
device (CVAD) needless hub. Several studies have consis-
tently found yeast and heavy bacterial contamination on the
surface of the CVAD hub. Our aim was to decrease line
manipulation in order to decrease our unit's CLABSI rate.
Implementation: In late 2010 our unit practice council
created newguidelines for accessing andmaintaining central
lines. These guidelines included: patients on continuous IVs
will not be disconnected to shower, walk, etc. and patients
whose lines are accessed greater than two time a day
(excluding labs) will remain connected continuously at
a provider prescribed rate. Our deﬁnition of each access
included one connection and disconnection. Nursing staff
were educated about the new guidelines via email and staff
meetings. Providers were educated during a Blood and
Marrow Transplant Program Quality Improvement
Committee meeting. In February of 2012, these guidelines
were revised to include the continuous connection of all
neutropenic patients receiving any IV ﬂuids or medications.
When not neutropenic, we continued to have patients with
greater than two accesses per day connected continuously.
Evaluation: During the 2010 calendar year our inpatient
BMT unit had 13 CLABSI, resulting in a 3.35 CLABSI rate per
1000 patient days. During the 2011 calendar year our inpa-
tient BMT unit had 5 CLABSI, resulting in a 1.27 CLABSI rate
per 1000 patient days. There was a 62 percent reduction in
CLABSI from 2010 to 2011. For the ﬁrst nine months of the
2012 calendar year our inpatient BMT unit has had 3 CLABSI,
resulting in a 1.07 CLABSI rate per 1000 patient days. There
was a 16 percent reduction in CLABSI from 2011 to the ﬁrst 3
quarters of 2012.Discussion: We were able to successfully implement a best
practice based intervention through creating new guidelines
for accessing and maintaining central lines and saw a signif-
icant decrease in our CLABSI rate.
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Improving Reliability of Immunosuppressant Sampling
Techniques
Michelle Kosik 1, Chrissy Boyd 1, Carolyn Zeh 1, Penny Odem1,
Monica Schlatter 2. 1 BMT, Presbyterian/St. Luke's Medical
Center, Denver, CO; 2 Colorado Blood Cancer Institute, Denver,
CO
Problem: The Colorado Blood Cancer Institute BMT Program
at Presbyterian/St. Luke's Medical Center, a member of the
Sarah Cannon Blood Cancer Network, performed 242
hematopoietic cell transplants in 2011. The program noted 14
conﬁrmed TAC/CSA lumen contaminations in 2010. In March
2011, auditing revealed 5 additional contaminations. This
prompted a process improvement initiative. Goals were to
improve quality outcomes by increasing reliability of TAC/
CSA levels and resulting dose adjustments and improve
patient satisfaction with the process (lumen contamination
necessitates peripheral sampling causing increased discom-
fort and risk for patients).
The BMT Leadership team reviewed potential causes:
Forty new staff hired; census and acuity were higher; Trav-
elers and ﬂoat staff were utilized. A process was needed to
ensure TAC/CSA levels were reliable and bedside caregivers
had appropriate knowledge to manage TAC/CSA infusions
and samplings.
Intervention: Immediate efforts focused on nursing staff
re-education.
1. Upon admission, nursing to designate a lumen for TAC/
CSA infusion.
2. No TAC/CSA sampling will be drawn from designated
lumen.
3. TAC/CSA infusion is primary line infusing into dedi-
cated port.
4. TAC/CSA infusion turned off 10 minutes prior to level
sampling.
The unit-based council led this initiative. They recom-
mended alerts to the special nature of these drugs. While
under review, another contamination occurred. Additional
recommendations made:
1. BMT Float guidelines reviewed -TAC/CSA process
added.
2. TAC/CSA process included in traveler orientation
3. RN Resource assigned to new hires, ﬂoats, and
travelers.
4. TAC/CSA education poster displayed on BMT units.
In February 2012, another contamination was noted. The
BMT Leadership team and unit-based council convened to
review additional opportunities.
1. Mandatory Healthstream education developed.
Healthstream is an electronic education system which
includes documentation of compliance.
2. Clamp unused lumens during sampling process.
3. Interdisciplinary collaboration to create a pop up
screen when medication is scanned-“Infuse in desig-
nated lumen ONLY. For help, see your charge nurse.”
